TESAMORELIN
Bundle & Save
| Quantity | Discount |
|---|---|
| 1 - 3 | 0% |
| 4 - 5 | 5% |
| 6 - 7 | 8% |
| 8 + | 10% |
| Quantity | Discount |
|---|---|
| 1 - 3 | 0% |
| 4 - 5 | 5% |
| 6 - 7 | 8% |
| 8 + | 10% |
Description
Tesamorelin is a growth hormone-releasing hormone analog designed for laboratory investigation of GHRH receptor signaling and growth hormone axis pathway models. Tesamorelin is studied in preclinical research for its relationship to pituitary signaling, GH release pathway modeling, IGF-1-associated signaling, metabolic regulation, and body-composition pathway research.
This compound is intended strictly for in vitro and preclinical laboratory research.
Specifications
Product Classification: Research-Use-Only (RUO)
Total Content: 10 mg lyophilized powder per vial
Compound: Tesamorelin research peptide
Form: Sterile lyophilized peptide compound
Purity: ≥99%
Storage: Store at −20 °C, protected from light
Packaging: Glass vial in protective sleeve
Applications
Intended for preclinical laboratory research only, including:
• GHRH receptor signaling studies
• Growth hormone axis pathway research
• IGF-1-associated pathway models
• Pituitary signaling experiments
• Metabolic regulation studies
• Body-composition pathway modeling
• Comparative GH secretagogue research
Warning
Not for human or animal use. For research purposes only.
Scientific Report
Abstract
Tesamorelin is a synthetic GHRH analog investigated for its role in growth hormone axis signaling. Tesamorelin is designed for laboratory research into GHRH receptor activation models, pituitary signaling, GH release pathways, IGF-1-associated response, metabolic regulation, and downstream cellular effects related to endocrine pathway modeling.
Mechanistic Pathway
Tesamorelin is designed around GHRH receptor and GH-axis pathway modeling.
GHRH Receptor Pathway
- Supports research into GHRH receptor activity
• Used in pituitary signaling models
• Studied for growth hormone axis response
Effect: Provides a model for GHRH receptor-mediated signaling.
Growth Hormone Axis Pathway
- Supports research into GH release pathway modeling
• Used in endocrine signaling studies
• Helps evaluate downstream hormonal pathway response
Effect: Enables investigation of growth hormone axis activity in controlled research systems.
IGF-1-Associated Pathway
- Supports research into IGF-1-associated signaling
• Used in metabolic and cellular growth pathway models
• Relevant to downstream endocrine response research
Effect: Provides a model for IGF-1-associated pathway investigation.
Pharmacokinetics / Research Profile
| Compound | Pathway | Research Notes |
| Tesamorelin | GHRH receptor / GH axis / IGF-1-associated signaling | GHRH analog model for endocrine and metabolic pathway research |
Dosing Models in Research
Used only in controlled in vitro and preclinical research models to study receptor signaling and endocrine pathway response. No human or animal-use instructions are provided.
Preclinical Research Highlights
- Studied as a GHRH receptor pathway model
• Used in GH-axis and pituitary signaling research
• Supports IGF-1-associated pathway investigation
• Relevant to metabolic regulation and body-composition models
• Useful for comparative research with other GH secretagogue peptides
Conclusion
Tesamorelin provides a research-use-only model for studying GHRH receptor activation, growth hormone axis signaling, IGF-1-associated pathways, endocrine response models, and metabolic regulation research.
